High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease. Hegde Y, Lazarus SK, Farraye FA, Hollnagel F, et al. J Clin Gastroenterol 2024 Nov 6. doi: 10.1097/MCG.0000000000002098.

Read + Share

Amedeo Smart

Independent Medical Education

Hegde Y, Lazarus SK, Farraye FA, Hollnagel F, et al. High Rate of Seroprotection With Heplisav-B in Patients With Inflammatory Bowel Disease. J Clin Gastroenterol 2024 Nov 6. doi: 10.1097/MCG.0000000000002098.
PMID: 40424081